2018 Press Releases-Archives-
The Gilbert Family Foundation has announced that UMass Medical School will receive funding from a $12 million gene therapy initiative to address the underlying cause of neurofibromatosis type 1.
John Erwin, a widely known and highly regarded government affairs leader, will join UMass Medical School in early January as vice chancellor for government relations.
Led by Guangping Gao, PhD, and Erik Sontheimer, PhD, scientists at UMass Medical School will work to develop technology to enable safe genome editing in patients, thanks to new grant funding from the National Institutes of Health.
Jeanne Lawrence, PhD, and Jaime Rivera, PhD, received a five-year, $2.8 million grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development at the National Institutes of Health to test a strategy in a mouse model for silencing the extra chromosome that causes Down Syndrome.
Michael Hirsh, MD, said doctors must take an active role in addressing the rising number of gun fatalities across the United States in a new opinion piece published Nov. 28 in The Conversation.
Victor Ambros, PhD, has been elected by his peers as a fellow of the American Association for the Advancement of Science.
Significant progress has been made in the effort to establish certified public health laboratories and safe blood collection and infection prevention and control practices in Liberia, according to David Chiriboga, MD, MPH, and colleagues, who recently provided an update work to strengthen health care services in the country.
A new study by Anastasia Khvorova, PhD, and Melissa Moore, PhD, at UMass Medical School and colleagues at Beth Israel Deaconess Medical Center and Western Sydney University, suggests that RNA interference therapy could be a potential strategy for the treatment of preeclampsia.
Matilde Castiel, MD, and Naheed Usmani, MD, shared their personal journeys of coming to the United States at the debut of the UMass Immigrant Stories series on Wednesday, Nov. 14.
The Substance Abuse and Mental Health Services Administration has awarded a grant to UMass Medical School to create a training program that will qualify medical, nurse practitioner and physician assistant students to provide medication-assisted treatment for opioid-addicted patients. Daniel Mullin, PsyD, is principal investigator on the grant.